Targeted therapies in solid tumors: Monoclonal antibodies and small molecules

Medicine and Dentistry

• Combination Therapy 100%
• Solid Malignant Neoplasm 100%
• Monoclonal Antibody 100%
• Targeted Therapy 100%
• Tyrosine-Kinase Inhibitor 66%
• Malignant Neoplasm 33%
• Comprehension 33%
• Development 33%
• Motivation 33%
• Carcinogenesis 33%
• Metastatic Carcinoma 33%
• Adverse Event 33%
• Signal Transduction 33%
• Cell Migration 33%
• Anticarcinogen 33%
• Tumor Progression 33%
• Tumor Cell 33%
• Cell Proliferation 33%
• Cell Survival 33%
• Side Effect 33%

Biochemistry, Genetics and Molecular Biology

• Small Molecule 100%
• Solid 100%
• Monoclonal Antibody 100%
• Protein-Tyrosine Kinase 66%
• Tyrosine Kinase Inhibitor 66%
• Development 33%
• Comprehension 33%
• Motivation 33%
• Growth 33%
• Signal Transduction 33%
• Cell Migration 33%
• Cell Survival 33%
• Cell Proliferation 33%
• Anticancer 33%
• Genetic Mechanism 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Solid Malignant Neoplasm 100%
• Monoclonal Antibody 100%
• Protein Tyrosine Kinase Inhibitor 66%
• Malignant Neoplasm 33%
• Carcinogenesis 33%
• Adverse Event 33%
• Survival 33%
• Neoplasm 33%
• Anticarcinogen 33%
• Metastasis 33%
• Tumor Growth 33%
• Cell Proliferation 33%
• Side Effect 33%